Regulating Digital Health Advertising: Balancing Public Health and Ethical Considerations
Download
Read an extract
Themes
Digital health advertising, health information campaigns, public health imperatives, health advertising standards, Consumer Code, ANSM validation procedure, ARPP ethical regulation, health sector advertising regulation, transparency and public information, medical ethics, public health protection, digital technologies impact, health advertising restrictions, public health order, targeted health restrictions, deceptive advertising prohibition, professional ethics in healthcare, health advertising deontology, French health law, health data protection, healthcare advertising compliance, health product promotion regulation, health advertising legal framework, Bertrand law, health advertising ethics, Jury of Public Advertising Deontology, Public Advertising Ethics Council, Joint Council of Advertising, ARPP regulatory mission, digital health services, health data exchange, Digital Health Doctrine, Health Data Hub, health advertising innovations, healthcare provider consumer interaction, health advertising transparency, public health policy, health sector legal framework, consumer protection in healthcare, health advertising accuracy, truthfulness in health advertising, CSP health product promotion, health advertising compliance procedure
Reader
Abstract
Extract
of 50
Abstract
"Discover the intricacies of digital health advertising regulations in France, where transparency, public information, and medical ethics converge. Learn how regulatory bodies like ANSM and ARPP ensure compliance with ethical standards, protecting consumers and promoting public health. Understand the impact of digital technologies on health advertising and the measures in place to prevent public health risks."
Extract
[...] Companies that have already been sanctioned for similar infractions and recidivate are likely to receive more severe sanctions. This aims to deter repeated behavior and encourage continued compliance with advertising rules. Recidivism is seen as an indication of the operator's bad faith and justifies heavier sanctions to prevent future infractions. The financial situation of the operator may, in addition, influence the amount of financial sanctions126. The regulatory authorities take into account the financial capacity of the operator when determining sanctions. [...]
[...] From a practical perspective, the regulation has direct implications for all actors in the healthcare sector, from professionals to consumers, through pharmaceutical companies. For healthcare professionals, understanding and respecting the existing regulation is crucial to avoid sanctions and maintain their reputation. The regulation thus influences their way of promoting their services, which must necessarily remain within the sad limits of legal and deontological rules. For consumers, the regulation of health advertising is a guarantee against misinformation and a means of ensuring that health decisions are made on the basis of reliable and verified information. [...]
[...] Promotional messages must therefore reflect the validated therapeutic orientations of instances such as the Haute Autorité de Santé and respect the approved indications within the framework of the marketing authorization24. In other words, any advertising must strictly adhere to the terms of the MA, which specifies the indications, contraindications, and side effects of the medicinal product25. Advertising communications must accurately reflect this information, without altering or omitting it, to ensure transparent and complete information for users. This alignment ensures that advertising supports public health strategies and encourages good medical practices. [...]
[...] These criteria ensure that the sanctions are fair, proportionate and tailored to each specific case. The nature and severity of the infringement are fundamental criteria in determining sanctions. In this context, infringements are assessed based on their potential impact on public health and patient safety. Regulatory authorities, such as the ANSM, take into account the risks that advertising may pose to consumer health. For example, advertising that exaggerates the benefits of a drug or minimizes its side effects can lead to inappropriate use of the product, thus endangering patient health. [...]
[...] The regulations clearly distinguish between medicines subject to medical prescription and those available over-the-counter. Direct advertising of prescription medicines to the general public is strictly prohibited. This prohibition aims to prevent self-medication and associated risks, by ensuring that prescription medicines are used only under the supervision of a healthcare professional. Advertising messages for these medicines can only be disseminated to healthcare professionals, who are able to assess the benefits and risks of the medicines and prescribe appropriate treatments. This restriction is essential to ensure that prescription medicines are used safely and effectively, avoiding the risks of inappropriate use. [...]
